Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 3
2021 pubmed 11 citations

Kisspeptin as autocrine/paracrine regulator of human ovarian cell functions: Possible interrelationships with FSH and its receptor.

Fabová. Zuzana Z; Loncová. Barbora B; Mlynček. Miloš M; Sirotkin. Alexander V AV

Key Findings

  • Granulosa cells produce kisspeptin and FSH receptors
  • Low‑dose kisspeptin (10 ng/mL) increases cell viability, proliferation, and releases progesterone, estradiol, IGF‑I, oxytocin, and PGE2
  • High‑dose kisspeptin (100 ng/mL) inhibits these effects and reduces FSH‑induced responses

Practical Outcomes

  • A small dose of kisspeptin might boost ovarian health and work together with FSH, but too much can suppress function. For biohackers interested in fertility or hormone balance, any kisspeptin use should start at very low levels and be approached cautiously, as the findings are from cell cultures, not human trials.

Summary

The study shows that human ovarian cells make kisspeptin and its receptor, and that a low amount of kisspeptin (10 ng/mL) helps these cells stay alive, multiply, and release key hormones, while a high amount (100 ng/mL) does the opposite and even blocks the normal actions of FSH, a hormone important for fertility.

Abstract

The present study aims to examine the role of kisspeptin (KP), FSH, and its receptor (FSHR), and their interrelationships in the control of basic human ovarian granulosa cells functions. We investigated: (1) the ability of granulosa cells to produce KP and FSHR, (2) the role of KP in the control of ovarian functions, and (3) the ability of KP to affect FSHR and to modify the FSH action on ovarian functions. The effects of KP alone (0, 10 and 100 ng/mL); or of KP (10 and 100 ng/mL) in combination with FSH (10 ng/mL) on cultured human granulosa cells were assessed. Viability, markers of proliferation (PCNA and cyclin B1) and apoptosis (bax and caspase 3), as well as accumulation of KP, FSHR, and steroid hormones, IGF-I, oxytocin (OT), and prostaglandin E2 (PGE2) release were analyzed by the Trypan blue exclusion test, quantitative immunocytochemistry, and ELISA. KP given at a low dose (10 ng/mL) stimulated viability, proliferation, inhibited apoptosis, promoted the release of progesterone (P4), estradiol (E2), IGF-I, OT, and PGE2, the accumulation of FSHR, but not testosterone (T) release. KP given at a high dose (100 ng/mL) had the opposite, inhibitory effect. FSH stimulated cell viability, proliferation and inhibited apoptosis, promoted P4, T, E2, IGF-I, and OT, but not PGE2 release. Furthermore, KP at a low dose promoted the stimulatory effect of FSH on viability, proliferation, P4, E2, and OT release, promoted its inhibitory action on apoptosis, but did not modify its action on T, IGF-I, and PGE2 output. KP at a high dose prevented and inverted FSH action. These results suggest an intra-ovarian production and a functional interrelationship between KP and FSH/FSHR in direct regulation of basic ovarian cell functions (viability, proliferation, apoptosis, and hormones release). The capability of KP to stimulate FSHR, the ability of FSH to promote ovarian functions, as well as the similarity of KP (10 ng/mL) and FSH action on granulosa cells' viability, proliferation, apoptosis, steroid hormones, IGF-I, OT, and PGE2 release, suggest that FSH influence these cells could be mediated by KP. Moreover, the capability of KP (100 ng/mL) to decrease FSHR accumulation, basal and FSH-induced ovarian parameters, suggest that KP can suppress some ovarian granulosa cell functions via down-regulation of FSHR. These observations propose the existence of the FSH-KP axis up-regulating human ovarian cell functions.

Study Information

Provider

pubmed

Year

2021

Date

2021-11-26T00:00:00.000Z

DOI

10.1016/j.repbio.2021.100580

Citations

11

References

48